Advertisement
| ocular pharmacokinetics ppt: Ocular Therapeutics Ashok Garg, 2013-03-31 The third edition of Ocular Therapeutics brings practitioners up to date with the latest advances in ophthalmic drugs. Divided into three sections, the book begins with discussion on the physiology of the eye, drug administration and the fundamental role of ocular therapeutics. The second section examines the application of ocular therapeutics in ophthalmic surgery for many different disorders and the final section discusses recent advances and future developments. This new edition has been fully updated with the addition of new drugs and delivery systems, covering all groups of drugs used worldwide in different clinical conditions of the eye. Written by recognised international experts, many from the USA, the book is presented in an easy to read format and includes nearly 430 well-illustrated colour figures, tables, flow diagrams and chemical formulas. Key points New edition bringing ophthalmologists up to date with latest advances in ophthalmic drugs Includes new drugs and delivery systems for all groups of drugs used worldwide Written by recognised international experts Nearly 430 figures, tables, flow diagrams and chemical formulas Previous edition published in 2006 |
| ocular pharmacokinetics ppt: Ophthalmic Drug Delivery Systems Ashim K. Mitra, 2003-03-25 The second edition of this text assembles significant ophthalmic advances and encompasses breakthroughs in gene therapy, ocular microdialysis, vitreous drug disposition modelling, and receptor/transporter targeted drug delivery. |
| ocular pharmacokinetics ppt: Pharmacology of the Eye M.L. Sears, 2012-12-06 Roots of the theory and practice of ocular pharmacology may be traced to the ancient Mesopotamian code of Hammurabi and then to several papyri reflecting the clinical interests of the Egyptians. The evolution of its art and science was irregularly paced until the nineteenth century when Kohler, in 1884, proved the anesthetic effect of cocaine on the cornea, and when Fraser, Laquer, Schmiedeberg, Meyer, and others studied the pharmacology of the autonomic nervous system by way of observations of the pupil. Advances in the past few decades have been nothing short of explosive. How can the student, physician, or basic research scientist stay in touch with these electrifying studies? To help with the answer to this question, the authors set as their goal the development of increased understanding so that the student, research scientist, and ophthalmologist can cope with the latest discoveries. The authors want to narrow what appears to be an ever-increasing gap between basic science and ophthalmology. The basic aspects of pharmacology have been presented in light of the natural physiology. In this regard, while distinctions among endogenous mechanisms, drug effects, and the pathogenesis of disease are to be separately recognized, appreciation must be given to the concept that both the desirable and unwanted manifestations or functions caused by either disease or drugs must very often represent a quantitative change in normal metabolic pathways. |
| ocular pharmacokinetics ppt: Clinical Ocular Pharmacology Jimmy D. Bartlett, Siret D. Jaanus, 1984 Written by experts in the field, this comprehensive resource offers valuable information on the practical uses of drugs in primary eye care. Discussions of the pharmacology of ocular drugs such as anti-infective agents, anti-glaucoma drugs, and anti-allergy drugs lead to more in-depth information on ocular drugs used to treat a variety of disorders, including diseases of the eyelids, corneal diseases, ocular infections, and glaucoma. The book also covers ocular toxicology, focusing on drug interactions, ocular effects of systemic drugs, and life-threatening systemic emergencies. |
| ocular pharmacokinetics ppt: Ocular Toxicology Keith Green, O. Hockwin, Ramesh C. Tripathi, I. Weisse, 2012-12-06 On behalf of the editorial board and the organizing committee of the 4th congress of the International Society of Ocular Toxicology (I SOT), held in AnnecyNeyrier du Lac, France, October 9 -13, 1994, we are pleased to present to the ocular toxicology community this indexed volume of our congress proceedings. The 4th congress was designed primarily to facilitate and update the knowledge in ocular electrophysiology and ocular pharmacokinetics, in both the clinical and preclinical aspects. The outcome of this 4th congress, established in this volume, is a useful contribution to the meth odology in both fields and will hopefully assist in the evaluation and interpretation of ocular findings recorded in animal studies on drugs and other chemicals, in order to protect human health. Undoubtedly, work on the mechanisms of ocular toxicology in the process of pharmaceutical development must continue and these proceedings, embodying the presented papers, will add to the data base. The editors, the congress organizing committee and the members of the International Society of Ocular Toxicology thank the speakers who gave their time, knowledge, and expertise to assist us in this project. The following manuscripts contain the main substance of each of the platform presentations and, in some cases, much more. Moreover, our thanks go to all the participants coming from a range of background- regulatory, academic and industrial -for their attention and excellent contributions during the discussion. |
| ocular pharmacokinetics ppt: Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, 2020-04-24 Among the many who serve in the United States Armed Forces and who are deployed to distant locations around the world, myriad health threats are encountered. In addition to those associated with the disruption of their home life and potential for combat, they may face distinctive disease threats that are specific to the locations to which they are deployed. U.S. forces have been deployed many times over the years to areas in which malaria is endemic, including in parts of Afghanistan and Iraq. Department of Defense (DoD) policy requires that antimalarial drugs be issued and regimens adhered to for deployments to malaria-endemic areas. Policies directing which should be used as first and as second-line agents have evolved over time based on new data regarding adverse events or precautions for specific underlying health conditions, areas of deployment, and other operational factors At the request of the Veterans Administration, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis assesses the scientific evidence regarding the potential for long-term health effects resulting from the use of antimalarial drugs that were approved by FDA or used by U.S. service members for malaria prophylaxis, with a focus on mefloquine, tafenoquine, and other antimalarial drugs that have been used by DoD in the past 25 years. This report offers conclusions based on available evidence regarding associations of persistent or latent adverse events. |
| ocular pharmacokinetics ppt: Neurogenesis and Neural Plasticity Catherine Belzung, Peter Wigmore, 2014-07-08 This volume brings together authors working on a wide range of topics to provide an up to date account of the underlying mechanisms and functions of neurogenesis and synaptogenesis in the adult brain. With an increasing understanding of the role of neurogenesis and synaptogenesis it is possible to envisage improvements or novel treatments for a number of diseases and the possibility of harnessing these phenomena to reduce the impact of ageing and to provide mechanisms to repair the brain. |
| ocular pharmacokinetics ppt: Genetics in Ophthalmology B. Wissinger, S. Kohl, U. Langenbeck, F. Bandello, 2003-07 The objective of this publication is to enhance mutual understanding and communication between ophthalmologists, molecular geneticists, genetic counselors and biomedical researchers. In the introductory chapter, current genetic paradigms and experimental genetic approaches relevant to the nature of hereditary disorders are discussed. The following contribution on the epidemiology of hereditary ocular disorders provides an excellent reference to geneticists as well as clinicians. Myopia is presented as an example of a complex clinical phenotype where genes and environment interact. Further molecular ophthalmogenetic topics, such as corneal dystrophies, cataract, glaucoma, opticus neuropathy, non-syndromic and syndromic pigmentary retinopathies, defects of vitamin A metabolism and macular dystrophies including age-related macular degeneration, are investigated in depth. The volume concludes with a survey of color vision deficiencies, a discussion of animal models and gene therapy, and a useful description of technical devices supporting patients who are losing sight. |
| ocular pharmacokinetics ppt: Intraocular Drug Delivery Glenn J. Jaffe, Paul Ashton, P. Andrew Pearson, 2006-03-13 This reference studies the most recent advances in the development of ocular drug delivery systems. Covering methods to treat or prevent ocular inflammation, retinal vascular disease, retinal degeneration, and proliferative eye disease, this source covers breakthroughs in the management of endophthalmitis, uveitis, diabetic macular edema, and age-r |
| ocular pharmacokinetics ppt: Critical Care Sedation Angelo Raffaele De Gaudio, Stefano Romagnoli, 2018-01-23 This book provides a comprehensive guide to delivering analgesia and sedation to critically ill patients for professionals and caregivers being involved in the management of these patients. It discusses and explains in detail the advantages and limitations of each drug and device using clear flowcharts, diagrams and tables. Furthermore, it explores the new drugs and – above all – new sedation delivery systems, particularly those for administering volatile anesthetics on ICUs. This book is a valuable and practical resource for anesthesists, intensivists and emergency physicians interested in sedation. |
| ocular pharmacokinetics ppt: Pharmacokinetics and Pharmacodynamics of Biotech Drugs Bernd Meibohm, 2006-12-13 This first ever coverage of the pharmacokinetic and pharmacodynamic characteristics of biopharmaceuticals meets the need for a comprehensive book in this field. It spans all topics from lead identification right up to final-stage clinical trials. Following an introduction to the role of PK and PD in the development of biotech drugs, the book goes on to cover the basics, including the pharmacokinetics of peptides, monoclonal antibodies, antisense oligonucleotides, as well as viral and non-viral gene delivery vectors. The second section discusses such challenges and opportunities as pulmonary delivery of proteins and peptides, and the delivery of oligonucleotides. The final section considers the integration of PK and PD concepts into the biotech drug development plan, taking as case studies the preclinical and clinical drug development of tasidotin, as well as the examples of cetuximab and pegfilgrastim. The result is vital reading for all pharmaceutical researchers. |
| ocular pharmacokinetics ppt: Laboratory Methods for Clinical and Public Health George P. Kubica, William E. Dye, United States. Public Health Service, 1967 |
| ocular pharmacokinetics ppt: Remington Education Pharmaceutics Shelley Chambers Fox, 2014-06-25 Remington Education: Pharmaceutics covers the basic principles of pharmaceutics, from dosage forms to drug delivery and targeting. It addresses all the principles covered in an introductory pharmacy course. As well as offering a summary of key information in pharmaceutics, it offers numerous case studies and MCQs for self assessment. |
| ocular pharmacokinetics ppt: Mycotic Keratitis Mahendra Rai, Marcelo Luis Occhiutto, 2019-07-23 Mycotic keratitis, also known asfungal keratitis, is commonly defined as an inflammation of the cornea. Globally, mycotic keratitis is more common as compared to others eye disorders. Though it occurs in all parts of the world it is more prevalent in tropical and subtropical areas. Mycotic Keratitis emphasizes novel perspectives on mycotic keratitis treatments and addresses different therapies used in treatment. The book is designed to be immensely useful for the students and teachers of microbiology, medicine, mycology, ophthalmology, biotechnology and nanotechnology. Medical microbiology researchers in general and medical mycology in particular will find it a valuable user-friendly book. |
| ocular pharmacokinetics ppt: Toxicological Profile for Isophorone , 1989 |
| ocular pharmacokinetics ppt: The ICU Book Paul L. Marino, Kenneth M. Sutin, 2012-02-13 This best-selling resource provides a general overview and basic information for all adult intensive care units. The material is presented in a brief and quick-access format which allows for topic and exam review. It provides enough detailed and specific information to address most all questions and problems that arise in the ICU. Emphasis on fundamental principles in the text should prove useful for patient care outside the ICU as well. New chapters in this edition include hyperthermia and hypothermia syndromes; infection control in the ICU; and severe airflow obstruction. Sections have been reorganized and consolidated when appropriate to reinforce concepts. |
| ocular pharmacokinetics ppt: Human Herpesviruses Ann Arvin, Gabriella Campadelli-Fiume, Edward Mocarski, Patrick S. Moore, Bernard Roizman, Richard Whitley, Koichi Yamanishi, 2007-08-16 This definitive and comprehensive account of the human herpes viruses provides an encyclopedic overview of their basic virology and clinical manifestations. This group of viruses includes human simplex type 1 and 2, Epstein Barr virus, cytomegalovirus and varicella-zoster virus. The diseases they cause are significant and often recurrent. Their prevalence in the developed world accounts for a major burden of disease, and as a result there is a great deal of research into the pathophysiology if infection and immunobiology. Another important area covered within this volume concerns antiviral therapy and the development of vaccines. All these aspects are covered in depth and the volume is fully up to date both scientifically and in terms of clinical guidelines for patient care. The text is generously illustrated throughout and fully referenced to the latest research and developments. |
| ocular pharmacokinetics ppt: Rational Therapeutics for Infants and Children Institute of Medicine, Division of Health Sciences Policy, Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Jonathan R. Davis, Sarah Pitluck, Peter Bouxsein, Ronald W. Estabrook, 2000-04-07 The Institute of Medicine's (IOM's) Roundtable on Research and Development of Drugs, Biologics, and Medical Devices evolved from the Forum on Drug Development, which was established in 1986. Sponsor representatives and IOM determined the importance of maintaining a neutral setting for discussions regarding long-term and politically sensitive issues justified the need to revise and enhance past efforts. The new Roundtable is intended to be a mechanism by which a broad group of experts from the public* and private sectors can be convened to conduct a dialogue and exchange information related to the development of drugs, biologics, and medical devices. Members have expertise in clinical medicine, pediatrics, clinical pharmacology, health policy, health insurance, industrial management, and product development; and they represent interests that address all facets of public policy issues. From time to time, the Roundtable requests that a workshop be conducted for the purpose of exploring a specific topic in detail and obtaining the views of additional experts. The first workshop for the Roundtable was held on April 14 and 15, 1998, and was entitled Assuring Data Quality and Validity in Clinical Trials for Regulatory Decision Making. The summary on that workshop is available from IOM. This workshop summary covers the second workshop, which was held on May 24 and 25, 1999, and which was aimed at facilitating the development and proper use of drugs, biologics, and medical devices for infants and children. It explores the scientific underpinnings and clinical needs, as well as the regulatory, legal, and ethical issues, raised by this area of research and development. |
| ocular pharmacokinetics ppt: Ocular Emergency Hua Yan, 2018-01-16 Ocular Emergency is a systematic, symptom based reference book for clinical practice guidance. This book aims to provide the most thorough knowledge and standard process to clinical practitioners, such as the nurses, medical students, residents, fellows and even ophthalmologists, to help them make the most appropriate decision on the management of patients who have suffered from urgent ocular conditions. The first three chapters provide the audiences general information of ocular emergency and the emergency room (ER), which will help them generate a clinical thinking. The following four chapters are symptom based discussion of common complaints of ocular emergency. These chapters contain almost all the symptoms the audiences will meet in the ER and covers hundreds of diseases the audiences may or may not think of which fits the symptom. They will help the readers to make the right diagnose and offer the best advice or treatment to the patients. The last two chapters provide the audiences the information of most urgent ocular traumas. For each disease, definition, etiology, clinical presentations and signs, treatment and typical clinical case with pictures or illustrative figures will be provided. In addition, each chapter will be provided with an algorithym(s) for differential diagnosis and treatment as a summary of the chapter. Hopefully this book may help the clinical practitioners to be fully prepared for any challenge of ocular emergency cases. |
| ocular pharmacokinetics ppt: Modern Pharmacology with Clinical Applications Charles R. Craig, Robert E. Stitzel, 1997 This fifth edition of this popular title has a much greater clinical focus. The editors have added clinical cases and vignettes to drug chapters and clinical summaries closing each chapter. |
| ocular pharmacokinetics ppt: Ivermectin and Abamectin William C. Campbell, 2012-12-06 Ivermectin and abamectin, members of the avermectin family of compounds, were introduced to the market in the 1980's as a veterinary antiparasitic drug and agricultural pesticide, respectively. Their acceptance and commercial success have been remarkable; both are highly effective and in worldwide use. The efficacy of ivermectin in river blindness has expanded the interest in its use in human medicine. In response to the intense scientific and industrial interest in ivermectin and abamectin and the likelihood that they will be forerunners of an expanding family of drugs, this comprehensive monograph satisfies the need for a review and synthesis of current knowledge about the use of these substances in crop protection as well as in cattle, sheep, swine, horses, dogs, cats, birds, fish, reptiles, and in man. This overview presents chemical, biochemical, and microbiological data, as well as pharmacological, safety, and environmental aspects and covers practical use of the compounds as antiparasitic and pesticide agents, as well as the available safety data that have emerged from the clinical experience with human applications. |
| ocular pharmacokinetics ppt: Pharmacokinetics and Adverse Effects of Drugs Ntambwe Malangu, 2018-05-23 This book is a fruit of a collaborative work from several international scientists. It will be a useful resource for researchers, students, and clinicians. Each individual chapter could serve as a prescribed reading for postgraduate students and clinicians specializing in and practicing clinical pharmacology and toxicology, pharmacotherapy and pharmacotherapeutics, pharmacovigilance, and toxicovigilance, as well as those involved in clinical research, drug discovery, and development. Every chapter in this book discusses and provides illustrations on the theme discussed based on authors' understanding and experience while summarizing existing knowledge. In doing so, each chapter provides a new insight that would benefit a novice as well as a seasoned reader in understanding the pharmacokinetic mechanisms and risk factors involved in the occurrence of adverse effects of drugs. |
| ocular pharmacokinetics ppt: Inborn Metabolic Diseases K. Tada, N.R.M. Buist, John Fernandes, Jean-Marie Saudubray, Georges van den Berghe, 2013-03-14 Five years after its predecessor, the second edition of Inborn Metabolic Diseases: Diagnosis and Treatment is appearing in an almost completely revised form. Its main feature is an even stronger emphasis on the clinical presentation of inborn errors of metabolism. For that reason, clinical approach has not only remained the central theme of the first chapter, but also become the starting point for all chapters dealing with either a single specific disorder or a group of diseases. Particular attention has been paid to clinical presentation under acute, subacute or chronic forms, to the appearance of initially aspecific symptoms evolving into a more characteristic syn drome at a later age, or vice versa, to clinical heterogeneity and its relation to genetic and biochemical heterogeneity. Brief reference to other diagnostic possibilities is also given in all disease-related chapters. Description of the metabolic derangements is restricted to the main pathophysiological features which provide the rationale for diagnosis and treatment. Methods to ascertain the diagnosis and diagnostic tests are listed comprehensively. As in the first edition, treatment is discussed extensively. Details are given for dietary treatment and drug administrations in acute situations, during infections and in maintenance treatment. The impressive progress of knowledge with respect to genetic lesions in inborn errors of metabolism remains condensed to the essentials. For more detailed information, particularly with respect to pathophysiology and genetics, we highly recommend the seventh edition of The Metabolic Basis of Inherited Disease, by Charles R. Scriver et al. (McGraw-Hill, 1995). |
| ocular pharmacokinetics ppt: Pharmacology Henry Hitner, 2005 |
| ocular pharmacokinetics ppt: Pharmaceutical Manufacturing Handbook Shayne Cox Gad, 2008-03-17 This handbook features contributions from a team of expert authors representing the many disciplines within science, engineering, and technology that are involved in pharmaceutical manufacturing. They provide the information and tools you need to design, implement, operate, and troubleshoot a pharmaceutical manufacturing system. The editor, with more than thirty years' experience working with pharmaceutical and biotechnology companies, carefully reviewed all the chapters to ensure that each one is thorough, accurate, and clear. |
| ocular pharmacokinetics ppt: Mammalian Sterols Damjana Rozman, Rolf Gebhardt, 2020-08-10 This book provides a comprehensive description of sterols and their novel biological roles in mammalian signaling, the book covers their biosynthesis and structure, describes sterol receptor -mediated actions, their tissue distribution and their role in disease. It offers insight into new research findings, focusing specifically on novel discoveries in bile acid and oxysterol signaling, including the lanosterol-to-cholesterol intermediates. Special attention is paid on the sex distribution of these sterols (male or female) and their sexually dimorphic roles in mammalian species, such as human, rat and mouse. Since sterols and drugs (xenobiotics) use many identical receptor-mediated signaling pathways, the book will be interesting for researchers working on the cross-road of endogenous and xenobiotic metabolism, it is intended for advanced students and scientists in molecular biology and biochemistry as well as for medical doctors in hepatology. |
| ocular pharmacokinetics ppt: Pocket Guide to Critical Care Pharmacotherapy John Papadopoulos, 2014-11-19 This is a no-nonsense guide to drug treatment in the intensive care unit. It covers the most commonly encountered conditions and is organized by system. Management of each condition is tersely outlined step-by-step in table format. The book also includes non-drug information that is essential to making informed, evidence-based pharmacotherapy decisions, such as risk scores, scales, and assessment tools. The Second Edition has been revised to reflect the latest critical care practice guidelines and up-to-date drug and non-drug information. |
| ocular pharmacokinetics ppt: Ocular Drug Delivery Systems Deepak Thassu, Gerald J. Chader, 2012-10-02 Drug discovery for ocular diseases has taken great strides in the last two decades. From cornea to choroid, new drugs have been formulated to address a great variety of ocular diseases. Yet without good drug delivery systems, these drugs are less effective than they might be or could even cause serious side effects. Ocular Drug Delivery Systems: Ba |
| ocular pharmacokinetics ppt: Real-time PCR M Dorak, 2007-01-24 With a variety of detection chemistries, an increasing number of platforms, multiple choices for analytical methods and the jargon emerging along with these developments, real-time PCR is facing the risk of becoming an intimidating method, especially for beginners. Real-time PCR provides the basics, explains how they are exploited to run a real-time PCR assay, how the assays are run and where these assays are informative in real life. It addresses the most practical aspects of the techniques with the emphasis on 'how to do it in the laboratory'. Keeping with the spirit of the Advanced Methods Series, most chapters provide an experimental protocol as an example of a specific assay. |
| ocular pharmacokinetics ppt: Lippincott's Review for Medical-surgical Nursing Certification Lippincott, 2011-10-20 Lippincott's Review for Medical-Surgical Nursing Certification, Fifth Editionprovides the information nurses need to achieve certification in the specialty of medical-surgical nursing. This helpful reference covers the broad range of content found on the actual examinations, including disorders by body system, such as coronary artery disease, COPD, and diabetes. The product reviews signs and symptoms, diagnostic tests, medical treatments, nursing assessments, and interventions for scores of health problems. Concise refreshers on wound care, perioperative nursing, collaborative practice, nursing research, and legal issues are also included. Review questions after each chapter and an end-of-book posttest help assess the nurse's preparedness for the exam. The book is appropriate for exams of both major certifying bodies: the ANCC and the AMSN. |
| ocular pharmacokinetics ppt: Handbook of Pharmaceutical Excipients Raymond C. Rowe, Paul J. Sheskey, Marian E. Quinn, 2009 Describes the chemical and physical properties of pharmaceutical excipients. Each monograph contains nonproprietary names, synonyms, chemical name and CAS registry number, empirical formula and molecular weight, structural formula, functional category, applications in pharmaceutical formulation or technology, description, pharmacopeial specifications, typical propertics, stability and storage conditions, incompatibilities, method of manufacture, safety, handling precautions, regulatory status, pharmacopeias, related substances, comments, specific references, general references, and authors. |
| ocular pharmacokinetics ppt: Rheology of Biological Systems American Institute of Chemical Engineers, 1973 |
| ocular pharmacokinetics ppt: Albert and Jakobiec's Principles and Practice of Ophthalmology Daniel M. Albert, Joan Whitten Miller, Dimitri T. Azar, Lucy H. Young, 2020 The 4th edition of this comprehensive and authoritative text is written by hundreds of the most distinguished authorities from around the world and edited by three leaders in the field, providing today's best answers to every question that arises in ones ophthalmology practice. Richly illustrated with thousands of high quality, full color, clinically-relevant images, Albert and Jakobiec's Principles and Practice of Ophthalmology, 4th Edition covers every scientific and clinical principle in ophthalmology, ensuring that the reader will always be able to find the guidance needed to diagnose and manage patients' ocular problems and meet today's standards of care. Written for practicing ophthalmologists and trainees, this book delivers in-depth guidance on new diagnostic approaches, operative techniques, and treatment options, as well as coherent explanations of every new scientific concept and its clinical importance. The 4th edition will prove to be the source every practicing clinician needs to efficiently and confidently overcome any clinical challenge they may face. Updates include new chapters on anterior and posterior segment diseases, as well as chapters more focused on treatment, plus thousands of new, high-quality, color images and illustrations, updated references, and information on the most cutting-edge technology used by clinicians in their practices today. Additionally, readers will enjoy the same, user-friendly, full-color design they remember from the previous edition, complete with many at-a-glance summary tables, algorithms, boxes, and diagrams that allow the reader to locate the assistance needed more rapidly than ever. |
| ocular pharmacokinetics ppt: Drug-induced Ocular Side Effects and Drug Interactions Frederick T. Fraunfelder, 1982 |
| ocular pharmacokinetics ppt: Veterinary Ocular Pathology Richard R. Dubielzig, Kerry L. Ketring, Daniel M. Albert, Gillian J. McLellan, 2010 A convenient, comprehensive and easy-to-use reference for veterinary pathologists, veterinary ophthalmologists, students and comparative vision scientists. Veterinary Ocular Pathology: A Comparative Review links the clinical features of ocular disease with gross and microscopic pathology to demonstrate the essential features observable during diagnosis. It is designed to be kept next to the microscope as an invaluable guide to accurate diagnosis in ocular pathology. the book presents a wide range of images of the highest quality. A unique and distinctive feature is the juxtaposition of clinic |
| ocular pharmacokinetics ppt: Ocular Infections Khalid F. Tabbara, Ahmed M. Abu El-Asrar, Moncef Khairallah, 2016-10-01 Ocular infections remain an important cause of ocular morbidity and loss of vision, yet many are preventable or curable. Early diagnosis and prompt treatment help in the control of such infectious disorders and the prevention of blindness. There are many infectious diseases of the eye and adnexa and knowledge of their diagnosis and management is essential to an optimal therapeutic outcome. This book provides the practitioner with the important information required to ensure appropriate diagnosis and management of ocular infectious diseases. Specific clinical signs and symptoms are outlined, and the role of specific diagnostic tests, including molecular biology techniques, is explained. All of the most common microorganisms are considered and current knowledge on the antimicrobial therapy of ocular infections is clearly summarized. Ocular Infections will be a great help to physicians as a guide to the care of patients with ocular infectious diseases. |
| ocular pharmacokinetics ppt: Becker-Shaffer's Diagnosis and Therapy of the Glaucomas Bernard Becker, Robert Nesbit Shaffer, Allan E. Kolker, John Hetherington, 1970 |
| ocular pharmacokinetics ppt: Gut Renovation Roshini Raj, 2023-03-14 Combining the latest developments and research discoveries, board-certified gastroenterologist and medical host on CNN and Fox News, Dr. Roshini Raj shows the ways in which the microbiome impacts overall well-being, and helps readers reset their biological clocks by improving their gut health. With one in four Americans suffering from digestive health issues every day, gut health has become an increasingly important part of wellness. With the human body, so many issues can be improved upon, or cured, by balancing the microbiome. But the microbiome--a community of bacteria, viruses, and yeasts that dwell in the body--has long been something that the average person can find baffling--and maybe a little bit gross. By offering simple and straightforward answers to questions like what one should be eating, what probiotics are, which vitamins and medicines really work, Dr. Raj demystifies the gut. She uses the idea of a home renovation to show how different organs and parts of the body can be renovated in order to optimize the microbiome. After all, balancing one's microbiome improves digestive health, brain function, emotional stability, the body's response to inflammation, immunity, and lessens premature aging. Melding the latest developments and discoveries in microbiome research, along with Dr. Raj's practical tips developed from her years of clinical experience, Gut Renovation shows readers how to turn back the biological clock and revamp the way they live forever. |
| ocular pharmacokinetics ppt: Alpha Herpesviruses Rozanne M. Sandri-Goldin, 2006 The alpha herpesviruses are an important group of viruses characterized by a short reproductive cycle, rapid destruction of the host cell, and the ability to replicate in a wide variety of host tissues. A key attribute of these viruses is the ability to establish lifelong latent infection in the peripheral nervous system of the natural host. Research into the molecular and cellular biology of the alpha herpesviruses has advanced greatly in recent years. Written by internationally recognized experts, this book highlights the more provocative and exciting findings in herpesvirus research. Each chapter is a review of a specific area with an emphasis on recent advances and the latest developments. The book examines multifunctional proteins, advances in DNA replication, new information on the regulation of gene expression, the emergence of new technologies, recent technological advances in fluorescent probes, the induction of apoptosis, the disruption of interferon, vaccine development, and drug design. With a specific focus on new and topical herpesvirus research, Alpha Herpesviruses is essential reading for everyone with an interest in herpesviruses and it is recommended reading for other scientists working in viral pathogenesis, viral genomics, and antiviral research. |
| ocular pharmacokinetics ppt: Toxicological Profile for Acetone , 2021 |
Ocular Oncology Program - Overvie…
Feb 21, 2025 · Mayo Clinic's Ocular Oncology Program offers a full range of eye …
Ocular migraine: When to seek help
Aug 1, 2024 · The term "ocular migraine" can be confusing. Headache …
Fatiga ocular - Síntomas y causas
Nov 7, 2024 · La fatiga ocular puede ser molesta. Sin embargo, …
Ocular rosacea - Symptoms and cau…
Apr 6, 2024 · Overview Ocular rosacea (roe-ZAY-she-uh) is inflammation …
Rosácea ocular - Diagnóstico y trata…
Apr 6, 2024 · Infórmate sobre los síntomas, las causas y el tratamiento …
Ocular Oncology Program - Overview - Mayo Clinic
Feb 21, 2025 · Mayo Clinic's Ocular Oncology Program offers a full range of eye cancer treatment options. There are many different types of eye cancer that can affect the surface of the eye, …
Ocular migraine: When to seek help - Mayo Clinic
Aug 1, 2024 · The term "ocular migraine" can be confusing. Headache specialists don't use this term anymore, but it has been used to describe migraines that occur with changes in vision. …
Fatiga ocular - Síntomas y causas - Mayo Clinic
Nov 7, 2024 · La fatiga ocular puede ser molesta. Sin embargo, normalmente no es grave y desaparece cuando descansas la vista o tomas otras medidas para reducir la molestia en los …
Ocular rosacea - Symptoms and causes - Mayo Clinic
Apr 6, 2024 · Overview Ocular rosacea (roe-ZAY-she-uh) is inflammation that causes redness, burning and itching of the eyes. It often develops in people who have rosacea, a chronic skin …
Rosácea ocular - Diagnóstico y tratamiento - Mayo Clinic
Apr 6, 2024 · Infórmate sobre los síntomas, las causas y el tratamiento de la rosácea ocular, una enfermedad del ojo que a menudo afecta a las personas que tienen rosácea en la piel.
A blow to the eye: Ocular and orbital trauma - Mayo Clinic
Apr 27, 2018 · Ocular and orbital injuries may require only observation or surgery spanning from simple to complex. A Mayo Clinic surgeon provides tips on this injury and the question of transfer.
Ocular rosacea - Diagnosis and treatment - Mayo Clinic
Apr 6, 2024 · Learn about symptoms, causes and treatments of ocular rosacea — an eye condition that often affects people who have skin rosacea.
Cirugía de ojos LASIK - Mayo Clinic
Dec 28, 2023 · La cirugía ocular LASIK es la cirugía refractiva láser más conocida y realizada para corregir problemas de visión. La cirugía LASIK puede ser una alternativa a los anteojos o …
Degeneración macular seca - Síntomas y causas - Mayo Clinic
Dec 6, 2024 · La visión central borrosa o reducida puede ser un signo de degeneración macular. Obtén información sobre los síntomas y el tratamiento de esta enfermedad ocular frecuente.
Ojo rosado (conjuntivitis) - Síntomas y causas - Mayo Clinic
Jan 10, 2025 · Esta afección ocular altamente contagiosa puede provocar picazón y molestias. Pero, al igual que el resfriado común, rara vez requiere medicamentos o quedarse en casa.
